1) Serous ovarian neoplasm
卵巢浆液性肿瘤
1.
Expression of MVD and bFGF in serous ovarian neoplasms
碱性成纤维细胞生长因子及微血管密度在卵巢浆液性肿瘤中的表达
2.
Methods Immunohistochemical method was used to examine the expression of VEGF in 76 cases of serous ovarian neoplasms.
目的探讨卵巢浆液性肿瘤组织中血管内皮生长因子的表达的临床意义。
2) Ovarian serous tumor
卵巢浆液性肿瘤
1.
Clinical signifinace of telomerease activity in human ovarian serous tumor;
卵巢浆液性肿瘤组织中端粒酶活性表达临床意义(英文)
2.
Objective: To investigate the expression of the tumor suppressor gene p16 in ovarian serous tumors and its relationship with clinicopathological features.
目的 :研究 p16在卵巢浆液性肿瘤中的表达 ,并探讨其表达与肿瘤的性质、临床分期、组织分化及腹水的关系。
3) Ovarian Serous Carcinoma
卵巢浆液性肿瘤
1.
The Expression of KDR Protein in Ovarian Serous Carcinoma and Its Clinical Relevance;
KDR蛋白在卵巢浆液性肿瘤组织中的表达及临床意义
2.
Objective: To study the expression of KDR protein in ovarian serous carcinoma , and compare with normal ovary tissue to find their clinical significanceMethods: Western Blotting were used to detect the expression of KDR protein in 38 cases of ovarian serous carcinoma、 14 cases of ovarian borderline serous tumors、 11 cases of ovarian benign serous tumors and 10 cases of normal ovary tissues.
目的:探讨卵巢浆液性肿瘤与正常卵巢组织中KDR蛋白的表达情况及临床意义。
4) serous ovarian neoplasm
浆液性卵巢肿瘤
1.
Differential diagnosis of CT on mucous and serous ovarian neoplasm;
粘液性与浆液性卵巢肿瘤的CT鉴别诊断
5) serou and mucous ovarian tumours
卵巢浆液性、粘液性肿瘤
补充资料：卵巢混合性生殖细胞-性索间质性肿瘤
卵巢混合性生殖细胞-性索间质性肿瘤
本瘤1921年首次由Masson描述，直到1972年由Telerman首次命名为本瘤，并沿用至今，本瘤病因尚不明了。发生年龄自新生儿到67岁妇女均可发生，少数为男性。临床表现：患者为正常女性及男性外表，女性病人可有下腹包块，发生蒂扭转时有下腹痛，并有急腹症症状，可有内分泌紊乱，性早熟表现，男性有睾丸增大。染色体核型分析均正常。内分泌检查与临床表现符合，肿瘤为单侧，圆形或卵圆形。表面光滑，直径2.5～30cm，实性肿瘤内有囊性区。切面灰白、灰红或淡黄至淡褐色。镜下有梭形细胞及生殖细胞。治疗：视情况采取单纯手术，或手术加放疗及化疗。需长期随访。预后：单纯本病者良好。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条